Company intelligence / Profile preview
Applied Lipid Therapeutics
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Applied Lipid Therapeutics is a biotechnology company focused on developing novel small molecule inhibitors for the treatment of metabolic and inflammatory diseases. The company's primary focus is on targeting aldose reductase, an enzyme involved in the polyol pathway that contributes to the development of diabetic complications. By inhibiting this enzyme, Applied Lipid Therapeutics aims to prevent or treat conditions such as diabetic cardiomyopathy, retinopathy, and nephropathy. The company is also exploring the potential of its lead candidates in rare metabolic disorders like galactosemia.
- Therapeutic areas
- CardiovascularMetabolic DisordersNephrologyOphthalmology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Applied Lipid Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Applied Lipid Therapeutics.